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Abstract
Overweight and obesity (OW/OB) impact half of the pregnancies in the United
States and can have negative consequences for offspring health. Studies are limited
on human milk alterations in the context of maternal obesity. Alterations in milk are
hypothesized to impact offspring development during the critical period of lactation.
We aimed to evaluate the relationships between mothers with OW/OB (body mass
index [BMI] ≥25 kg/m2), infant growth, and selected milk nutrients. We recruited
mother–infant dyads with pre-pregnancy OW/OB and normal weight status. The pri-
mary study included 52 dyads with infant growth measures through 6 months.
Thirty-two dyads provided milk at 2 weeks, which was analysed for macronutrients,
long-chain fatty acids, and insulin. We used multivariable linear regression to examine
the association of maternal weight status with infant growth, maternal weight status
with milk components, and milk components with infant growth. Mothers with
OW/OB had infants with higher weight-for-length (WFL) and BMI Z-scores at birth.
Mothers with OW/OB had higher milk insulin and dihomo-gamma-linolenic, adrenic,
and palmitic acids and reduced conjugated linoleic and oleic acids. N6 long-chain
polyunsaturated fatty acid (LC-PUFA)-driven factor 1 was associated with higher
WFL, lower length-for-age (LFA), and lower head circumference-for-age Z-scores
change from 2 weeks to 2 months in human milk-fed infants, whereas N6 LC-PUFA-
driven factor 5 was associated with lower LFA Z-score change. Human milk composi-
tion is associated with maternal pre-pregnancy weight status and composition may
be a contributing factor to early infant growth trajectory.
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1 | INTRODUCTION
In the United States, over 50% of pregnancies are complicated by over-
weight or obesity (American College of Obstetricians and Gynecologists,
2013). Obesity has adverse effects on maternal health, impacts fetal
development, and programmes lifelong offspring risk for obesity (Leddy,
Power, & Schulkin, 2008; Poston, Harthoorn, & Van Der Beek, 2011). In
addition to the in utero environment, rapid weight gain in infancy has
been linked to childhood obesity risk, pointing to the neonatal period
as a critical window for adipose tissue development (Monteiro &
Victora, 2005; Weng, Redsell, Swift, Yang, & Glazebrook, 2012).
The lactation period is a window during which alterations in milk
composition impact infant metabolic outcomes (Prentice et al., 2016). In
the setting of maternal disease, there are differences in milk nutrients,
oxidative stress and inflammatory markers, and bioactive factors, many
of which have been implicated in programming offspring growth and
appetite (Ellsworth, Harman, Padmanabhan, & Gregg, 2018; Young,
Johnson, & Krebs, 2012). Animal models demonstrate that maternal obe-
sity and high-fat diet influence milk composition, leading to increased
insulin and altered fatty acids in milk of obese dams and obesity in adult
offspring (Gorski, Dunn-Meynell, Hartman, & Levin, 2006; Wahlig et al.,
2012). Limited human research on maternal weight status during lacta-
tion has shown differences in milk composition of nutrients, hormones,
bioactives, and microbiota with suggested links to infant growth (Eriksen,
Christensen, Lind, & Michaelsen, 2018; Fields et al., 2017; Makela,
Linderborg, Niinikoski, Yang, & Lagstrom, 2013; Panagos et al., 2016).
Milk composition has a high degree of variability despite well-
conserved macronutrients, with maternal weight status contributing
to this variation (Ballard & Morrow, 2013). Maternal weight status has
been associated with increased factors promoting adipogenesis
including N6 long-chain polyunsaturated fatty acids (LC-PUFAs) and
metabolic regulating factors such as insulin (Ahuja et al., 2011; Amaral,
Marano, Oliveira, & Moreira, 2019; Chan et al., 2018; Ley, Hanley,
Sermer, Zinman, & O'Connor, 2012; Makela et al., 2013; Young et al.,
2017). The impact of maternal weight status on milk composition may
be an important aspect of developmental programming; however, the
degree to which milk composition influences infant growth remains an
area for exploration. Recent studies have suggested roles for mature
milk growth factors, inflammatory factors, and fatty acids in the
development of infant body composition (Fields & Demerath, 2012;
Much et al., 2013). The aims of this study were twofold: (a) evaluate
the influence of pre-pregnancy overweight and obesity on infant
growth and early milk composition in the first weeks of life and
(b) investigate the potential for milk composition to impact infant
growth trajectories during the first 6 months of life.
2 | METHODS
2.1 | Study overview
Mother–infant dyads were recruited after written informed consent
was obtained from mothers for their own participation and assent on
behalf of their infant. Mothers were given detailed instructions for
milk collection. Maternal demographics were obtained through paper
survey with health history obtained through medical record review.
Infant characteristics, growth measurements, and nutrition source
were obtained through medical record review at birth and well child
appointments at 2 weeks, 2 months, and 6 months. Participants were
given a stipend for their involvement. The Institutional Review Board
of the University of Michigan (HUM00107801) and Saint Joseph
Mercy Hospital (HSR -17-1686) approved this study protocol.
2.2 | Participants
Fifty-five dyads were enrolled peripartum while admitted for birth at
two participating hospitals in Ann Arbor, Michigan, USA. Three dyads
opted out of the study. Dyads were categorized on the basis of
maternal pre-pregnancy body mass index (BMI) into normal weight
(NW; BMI <25.0 kg/m2) and overweight or obese (OW/OB; BMI
≥25.0 kg/m2). Pre-pregnancy BMI was obtained through the medical
record by obstetrics recorded pre-pregnancy weight or early first tri-
mester weight with BMI then calculated using recorded height. Inclu-
sion criteria included maternal age > 18, gestational age ≥ 35 weeks,
and healthy singleton birth with no maternal diabetes. Dyads were
enrolled if the mother intended to breastfeed but not excluded if for-
mula was supplemented. Infant growth trends and milk composition
associations with growth were excluded for those receiving exclusive
formula feedings.
2.3 | Milk collection
The research team verbally instructed mothers on milk sample collec-
tion with a written protocol provided. Samples were collected by
Key messages
• Animal models of maternal obesity have shown roles for
milk nutrients, fatty acids, oxidative stress markers,
inflammatory markers, hormones, and bioactive factors in
programming of offspring growth. Human studies with
longitudinal infant outcomes are limited.
• This study is novel in investigating the impact of pre-
pregnancy overweight and obesity on the early macronu-
trient, fatty acid profile, and insulin content of human
milk during the period of transition from colostrum to
mature milk and the association with infant growth
through 6 months.
• This study found associations of higher milk N6 LC-
PUFAs with infant growth trajectory.
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mothers at home on the morning of their infant's physician visit
near 2 weeks of life, on average at postpartum day 16. This time
point was selected given expected improvement in milk supply to
allow for milk in transition to mature milk to be provided without
limiting the infant supply. Mothers collected nonfasting milk
between 8:00 a.m. and 10:00 a.m. at least 2 hr after feeding their
infant. Mothers provided milk by hand expression or pumping emp-
tying an entire single breast. The method of expression and which
breast to empty were based on maternal preference. Milk was
expressed into a container then inverted to mix prior to transfer of
25 ml into glass vials in 5-ml aliquots. Samples were stored in
mother's home freezer then transported to clinic on ice for storage
at −20C for less than 1 week before transport on ice for final
freezing at −80C. Prior to analysis, samples were thawed on ice.
Milk collection protocol was based on published milk collection
with modifications as described for our study design and popula-
tion (Fields & Demerath, 2012).
2.4 | Milk analysis
2.4.1 | Macronutrients
Whole milk samples were analysed using a mid-infrared spectros-
copy macronutrient analyser (MIRIS HMA™, Uppsala, Sweden). For
macronutrient analysis of carbohydrate, protein, fat, and total
energy, 5 ml milk sample was warmed to 40C in a bead bath then
underwent ultrasonic homogenization prior to immediate analysis
per manufacturer protocol. Analysis was performed in duplicate for
reproducibility, and average value was used in analysis. As control
prior to analysis, internal calibration using standards provided by
MIRIS HMA™ was completed and verified with the range of
targeted values established by the manufacturer. MIRIS HMA™
reported repeatability for fat, crude protein, true protein ≤0.05
g/100 ml, and carbohydrate ≤0.08 g/100 ml and accuracy for fat
±12%, crude protein, true protein, and carbohydrate ±15%. Milk
macronutrient analysis was not completed for samples with under
5-ml volume available.
2.4.2 | Fatty acid profiles
Lipids were extracted from milk samples (30 μl) following the
method of Bligh and Dyer (1959) with modifications. The volume
of the milk was adjusted to 600 μl with water followed by addition
of 2.25 ml of a mixture of chloroform-methanol (1:2) containing
0.01% of butylated hydroxytoluene and 10 μl of 4-mM hep-
tadecanoic (C17:0) acid as an internal standard. The mixture was
homogenized on a vortex mixer. The homogenized sample was fur-
ther treated with 0.75 ml each of chloroform and aqueous sodium
chloride (NaCl 0.9%) solution followed by mixing and centrifugation
at 3000 rpm for 5–6 min at 4C on a tabletop centrifuge. The
upper aqueous layer was discarded by aspiration under vacuum,
and the lower organic (chloroform) layer containing the lipids was
separated out, transferred into a screw-capped glass tube, and
saved at −20C unless used as follows.
The fatty acid portion of the lipids were converted into their
methyl esters with boron trifluoride-methanol (BF3-methanol) as
described before with slight modification (Morrison & Smith, 1964).
The solvents of the lipid extracts were removed under nitrogen. To
the dry residues left in the screw-capped glass tube, 2 ml of BF3-
methanol (14% solution from Sigma, Saint Louis, MO, USA) was
added; the mixtures were incubated at 60C for 2–2.5 hr. The
fatty acid methyl esters (FAMEs) were extracted in hexane by
adding 2 ml of hexane and 1 ml of water, mixing and centrifuging
as above followed by transferring the upper hexane layer into a
separate glass tube. The volume of the solvent was reduced under
nitrogen, and the crude FAMEs were purified by applying on thin-
layer chromatographic plate (20 × 20 cm, silica gel 60, Merck
KGaA, Darmstadt, Germany, now operates as Millipore Sigma, Bur-
lington, MA, USA). The plate was developed with a solvent mixture
of hexane–diethyl ether–acetic acid (80 ml–20 ml–1.5 ml, respec-
tively). Methyl ester bands were identified by comparing the reten-
tion flow of a commercial standard FAME (methyl heptadecanoate)
applied on the same thin-layer chromatographic plate on a side.
The powder of the identified methyl ester was scrapped out into a
test tube and extracted with 2 ml of chloroform by mild sonication
on a bath sonicator followed by centrifugation at room tempera-
ture (22C) and then transferring the clear chloroform layer into a
separate tube. The solvents were removed completely under nitro-
gen, purified methyl esters redissolved in 100 μl of hexane, and
the fatty acid compositions of the lipids analysed by gas chroma-
tography (GC).
GC analyses were performed on an Agilent GC (Santa Clara,
CA, USA) model 6890N equipped with flame ionization detector,
an auto sampler model 7693, and Chemstation software (version
C.01.04) for data analysis. The GC column used was Agilent HP
88, 30-m, 0.25-mm I.D., and 0.20-μm film thickness. Hydrogen was
used as a carrier gas and for the flame ionization detector, and
nitrogen was used as a makeup gas. Analyses were carried out
injecting 1 μl of sample via autoinjector mode. Temperature
programmes of 125C for 0 min, 125–145C at 39.52C/min, hold-
ing 145C for 5.3 min, and 145–220C at 9C/min, holding 220C
for 5 min were used. Each sample run was completed in
19.14 min. A calibration curve was prepared using known amounts
of methyl heptadecanoate and other commercially available stan-
dard methyl ester mixtures containing saturated and unsaturated
carbon chain length from 12 through 22 carbons on GC and using
the peak area ratio response of each methyl ester with respect to
methyl heptadecanoate. The fatty acid methyl ester components in
the sample were identified comparing the retention time of the
commercial standards and quantified with respect to the amount
of methyl heptadecanoate internal standard added in each sample
during liquid extraction and the peak area ratio response as in the
calibration curve prepared. The quality control was done by ana-
lysing a pooled sample (indistinguishable from the study samples)
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periodically and also before analysis of any study samples to
ensure GC performances with respect to separation, retention
times, and peak response. The coefficient of variation was deter-
mined after multiple runs of the sample injection volume of the
same pooled sample and calculating area percentages of methyl
esters, their mean (average) values, and standard deviations and
then evaluating the ratio of the standard deviation to the mean.
The coefficient of variation for GC analysis was found to be within
2.3% to 3.7%. Individual long-chain fatty acid (LCFA) concentra-
tions were calculated as a percentage of total LCFAs for 33
saturated, monounsaturated, and polyunsaturated LCFAs. N6:N3
LC-PUFA ratio was calculated on the basis of total N6 and total
N3 concentrations.
2.4.3 | Insulin
Whole milk samples were delipidated to isolate the skim milk layer
by centrifugation at 720 relative centrifugal force for 20 min at
4C, followed by removal of the bottom skim milk layer using a
21-gauge needle with 1-ml syringe which is done twice. Using
25 μl of undiluted skim milk, insulin was analysed using Mercodia
Insulin ELISA 10-1113-01 according to the manufacturer protocol
with Mercodia Diabetes Antigen Control Human Low and High
10-1134-01 (Mercodia Ab, Uppsala, Sweden; Whitmore, Trengove,
Graham, & Hartmann, 2012). Analysis was performed in duplicate,
and the average value was used in analysis. Milk insulin analysis
was not completed for all samples; if only a minimal volume is
available, then milk was prioritized for lipid analysis.
2.5 | Infant growth measurements
Infant anthropometrics were obtained by medical record review
using birth and paediatric well-child routine visits at birth, 2 weeks,
2 months and 6 months. Age- and sex-specific Z-scores for
weight-for-age (WFA), length-for-age (LFA), head circumference-
for-age (HCA), weight-for-length (WFL), and BMI using the World
Health Organization (WHO) growth standard for infants 0 to
2 years of age were extracted (WHO Multicentre Growth Refer-
ence Study Group, 2006).
2.6 | Statistical analysis
We described participant demographics including 52 dyads for
growth and 32 dyads for which milk analysis was completed using
descriptive statistics (Table 1). In all multivariable models, we
included covariates on the basis of prior knowledge of variables
that are associated with the independent variable of interest and
could be a potential determinant of the dependent variable
assessed in each model (Hernan, Hernandez-Diaz, Werler, & Mitch-
ell, 2002; Schriger, 2008).
2.6.1 | Maternal weight status and infant growth
We examined associations of maternal weight status with infant
growth at birth, 2 weeks, 2 months, and 6 months of age using multi-
variable linear regression based on 52 mother–infant dyads. In these
models, OW/OB versus NW (referent) was the independent variable
of interest, and infant WFA Z-score, WFL Z-score, BMI-Z-score, LFA
Z-score, and HCA Z-score at each of the time points were the out-
comes of interest. In these models, we adjusted for the following
covariates: infant sex and feeding type (milk only or milk + formula) at
the time of anthropometric assessment. For time points beyond birth,
we also adjusted for the anthropometric indicator of interest at birth;
by doing so, the estimate of association can be interpreted as the
average change in anthropometry from birth, while accounting for size
at birth. In addition to evaluating maternal weight status as OW/OB
versus NW, we also examined it as a continuous variable multiplied by
1 standard deviation (SD) of pre-pregnancy BMI for the study sample
to enhance biological relevance, as we have previously done in other
studies (Centers for Disease Control and Prevention, 2019; Perng,
Gillman, Mantzoros, & Oken, 2014).
2.6.2 | Maternal weight status and human milk
composition
We examined the relationship between maternal weight status and
milk composition, including macronutrients, LCFAs, N6:N3 LC-PUFA
ratio, and insulin for the 32 mother–infant dyads from which milk
samples were provided. Here, we explored the ratio of N6:N3 as well
as the percentage of fatty acid compared with the total LCFAs using
Student's t tests and Mann-Whitney U test as appropriate on the basis
of normality of data distribution.
To process the LCFA data for regression analysis, we used prin-
cipal components analysis (PCA) to consolidate the 33 lipids into
five factors on the basis of the Scree plot and eigenvalues >1 simi-
lar our previously published work (Perng et al., 2014; Perng et al.,
2017). Use of PCA to derive factors results in clusters of lipid
metabolites that are correlated with one another and have been
shown to reflect true biological processes (e.g., the clustering of
branched chain amino acids and acylcarnitines in a metabolomics
analysis of childhood obesity reflects the fact that acylcarnitines are
downstream catabolites of branched chain amino acid catabolism;
Perng, Gillman, Fleisch, et al., 2014). These factors each have a con-
tinuous and normally distributed score that represents distinct lipid
metabolite patterns. A higher and positive score for a given factor
means that a woman's milk lipid composition more closely repre-
sents that particular factor. Conversely, a lower and negative score
for a pattern suggests that a woman's milk lipid composition does
not reflect the pattern captured by a given factor. We examined
associations of maternal weight status with milk composition, we
used linear regression models where OW/OB versus NW was the
dichotomous independent variable, and each of the milk compo-
nents were assessed as separate continuous outcomes.
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2.6.3 | Human milk composition and infant growth
We explored associations of milk composition with infant growth
from 2 weeks to 2 months and 2 to 6 months of age for the
32 mother–infant dyads from which milk samples were provided.
Here, we used multivariable linear regression models where each
milk component was entered as a continuous independent variable
and change in the anthropometric indicators were the outcomes. In
these models, we also accounted for infant sex. Given the variation
in infant fluid status at birth, the 2-week time point was used to
assess change in growth. We evaluated associations with infant
growth for infants receiving any type of nutrition (which included
any degree of human milk feedings at 2 weeks, 2 months, or
6 months) with additional analysis including only those infants
receiving exclusive human milk (EHM) feedings at 2 weeks,
2 months, and 6 months.
In the multivariable analyses, we focused our interpretation on
the direction and magnitude of beta estimates and the precision of
the 95% confidence intervals (CIs), while also considering statistical
significance as p < .05. All models met standard assumptions of multi-
variate normality.
All analyses were carried out in SAS version 9.4 (Cary, NC, USA)
with the exception of demographics and individual LCFA analysis,
which was carried out using GraphPad Prism 8.0 (GraphPad Software,
San Diego, CA, USA).
3 | RESULTS
Characteristics of the 52 dyads enrolled from which the 32 milk
samples were collected are presented in Table 1. Birth was at term
gestational age with an equal percent of male and female infants of
primarily Caucasian race/ethnicity. Of the 52 infants, 17.3% were
large for gestational age, defined as birthweight percentile greater
than the 90th percentile, and no infants were small for gestational
age. For 32 dyads with milk available for analysis, six mothers with
OW/OB provided supplemental formula plus human milk at 2 weeks.
At 2 months, three mothers with OW/OB provided supplemental
formula plus human milk. By 6 months of age in our cohort of
52 dyads, one infant of NW and seven infants of OW/OB had
transitioned to exclusive formula feedings, whereas two infants of
NW and eight infants of OW/OB received supplemental formula
plus human milk.
3.1 | Maternal weight status and infant growth
The associations of maternal pre-pregnancy BMI category
(NW versus OW/OB) with infant WHO Z-score anthropometry from
birth to 6 months are shown inTable 2. Maternal OW/OB was associ-
ated with higher infant WFL Z-score and BMI Z-score only at birth.
There were no associations at the later time points.
TABLE 1 Participant characteristics
Participant characteristics (n = 52) Participant characteristics with human milk (n = 32)
NW (n = 22) OW/OB (n = 30) NW (n = 16) OW/OB (n = 16)
Maternal age (years) 31.1 (3.9) 29.1 (4.7) 30.9 (4.1) 29.9 (3.8)
Maternal pre-pregnancy
BMI (kg/m2)
21.1 (2.2) 31.4 (4.8) 21.3 (2.0) 30.2 (4.5)
Maternal race or ethnicity (%)
Caucasian 12 (54) 22 (73) 9 (56) 14 (88)
African American 1 (5) 5 (17) 0 (0) 1 (6)
Hispanic 1 (5) 0 (0) 1 (6) 0 (0)
Asian 4 (18) 0 (0) 4 (25) 1 (6)
Other/not available 4 (18) 3 (10) 2 (13) 0 (0)
Gestational age 40 weeks 0 days (7 days) 39 weeks 6 days (8 days) 40 weeks 0 days (7 days) 39 weeks 5 days (10 days)
Mode of birth (%)
Vaginal 14 (64) 17 (57) 10 (62) 12 (75)
C-section 8 (36) 13 (43) 6 (38) 4 (25)
Infant sex (%)
Male 10 (45) 13 (43) 7 (44) 8 (50)
Female 12 (55) 17 (57) 9 (56) 8 (50)
Infant birthweight (kg) 3.5 (0.4) 3.6 (0.4) 3.5 (0.3) 3.5 (0.4)
Infant age at 2 week
collection (days)
16.1 (2.9) 16.2 (3.0) 16.1 (3.2) 16.7 (3.3)
Note. Data presented as mean (standard deviation) or mean (percentage) as appropriate. Bolded font indicates statistical significance at p < .05 based on a t
test.
Abbreviations: BMI, body mass index; NW, mothers with normal weight; OW/OB, mothers with overweight or obesity.
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3.2 | Maternal weight status and human milk
composition
Milk samples were analysed for LCFA profiles as presented in
Table 3. The distributions of milk components are presented in
Figure S1. We observed no significant difference in N6:N3 LC-PUFA
ratio by maternal weight status (NW 12.82 vs OW/OB 12.98). How-
ever, individual LCFAs were statistically higher in OW/OB including
palmitic acid, dihomo-gamma-linolenic acid (DGLA), and adrenic acid.
Oleic acid and conjugated linoleic acid were lower in OW/OB. Linear
regression analysis of maternal pre-pregnancy weight status and
LCFA profiles demonstrated positive association with palmitic acid,
adrenic acid, DGLA and negative association with oleic acid as shown
in Figure S2. Milk LCFAs were further assessed using PCA to create
latent variables representing metabolite patterns (“factors”). We
retained five factors from the PCA, which together accounted for
66.8% of variance in the original LCFA data set. This is compared
with other analyses using PCA to reduce high-dimensional data into
factor scores (Perng et al., 2017; Perng, Gillman, Fleisch, et al., 2014).
LCFA composition and factor loadings for key metabolites within
each factor (factor loading >|0.4|) are shown in Table S1. Lipid factor
1 is primarily composed of N6 LC-PUFAs including DGLA,
bosseopentaenoic acid, and arachidonic acid (AA) in addition to
gadoleic acid. Saturated LCFAs comprise lipid factor 2, including
stearic acid, arachidic acid, pentadecyclic acid, and palmitic acid. Lipid
factor 3 is derived from mainly N3 LC-PUFAs including doco-
sahexaenoic acid (DHA), docosapenaenoic acid (DPA) and well as a
N6 LC-PUFA docosadienoic acid which is an elongation product of
DGLA. Lipid factor 4 contains very long-chain fatty acids with 22-24
carbons including lignoceric acid, nervonic acid, brassidic acid, and
TABLE 2 Adjusted associations of maternal pre-pregnancy BMI with infant anthropometry at birth, 2 weeks, 2 months, and 6 months of age
among mother–infant dyads
Time Point
Mean ± SE β (95% CI)
Per 1 SD (6.4 kg/m2) BMIcNW (n = 22) OW/OB (n = 30) OW/OB vs. NW
Birtha
WFA z-score 0.41 ± 0.17 0.52 ± 0.15 0.11 [-0.31, 0.54] 0.03 [-0.19, 0.24]
WFL z-score −1.48 ± 0.24 −0.53 ± 0.21 0.95 [0.34, 1.56] 0.40 [0.09, 0.71]
BMI z-score −0.79 ± 0.20 −0.23 ± 0.17 0.56 [0.05, 1.06] 0.24 [−0.02, 0.49]
LFA z-score 1.51 ± 0.23 1.02 ± 0.19 −0.50 [−1.06, 0.07] −0.24 [−0.52, 0.05]
HCA z-score 0.49 ± 0.21 0.20 ± 0.18 −0.29 [−0.81, 0.24] −0.08 [−0.34, 0.19]
2 weeks of ageb
WFA z-score −0.01 ± 0.31 −0.27 ± 0.25 −0.26 [−0.64, 0.13] −0.05 [−0.26, 0.14]
WFL z-score −0.94 ± 0.43 −0.88 ± 0.35 0.07 [−0.49, 0.63] −0.07 [−0.36, 0.22]
BMI z-score −0.56 ± 0.39 −0.58 ± 0.32 −0.02 [−0.52, 0.47] 0.06 [−0.20, 0.32]
LFA z-score 0.74 ± 0.47 0.44 ± 0.38 −0.30 [−0.88, 0.29] −0.05 [−0.37, 0.26]
HCA z-score 0.78 ± 0.47 0.38 ± 0.38 −0.40 [−0.99, 0.19] −0.21 [−0.53, 0.11]
2 months of ageb
WFA z-score −0.43 ± 0.23 −0.43 ± 0.17 0.00 [−0.35, 0.35] 0.08 [−0.10, 0.25]
WFL z-score −0.59 ± 0.42 −0.77 ± 0.31 −0.18 [−0.86, 0.50] 0.03 [−0.30, 0.37]
BMI z-score −0.60 ± 0.35 −0.79 ± 0.26 −0.19 [−0.74, 0.36] 0.03 [−0.25, 0.30]
LFA z-score −0.05 ± 0.29 0.23 ± 0.22 0.28 [−0.17, 0.74] 0.12 [−0.11, 0.35]
HCA z-score 0.14 ± 0.38 0.20 ± 0.28 0.06 [−0.52, 0.65] 0.05 [−0.25, 0.35]
6 months of ageb
WFA z-score 0.45 ± 0.30 0.34 ± 0.23 −0.11 [−0.59, 0.37] 0.11 [−0.14, 0.36]
WFL z-score −0.09 ± 0.33 −0.19 ± 0.25 −0.11 [−0.67, 0.45] 0.12 [−0.16, 0.41]
BMI z-score −0.18 ± 0.33 −0.30 ± 0.24 −0.13 [−0.67, 0.42] 0.10 [−0.17, 0.38]
LFA z-score 0.79 ± 0.41 0.97 ± 0.31 0.17 [−0.50, 0.85] 0.17 [−0.18, 0.52]
HCA z-score −1.01 ± 2.69 1.54 ± 2.01 2.55 [−1.80, 6.90] 2.04 [−0.17, 4.25]
Note. Bolded font indicates statistical significance at p < .05 based on a Wald Chi-squared test.
Abbreviations: BMI, body mass index; HCA, head circumference-for-age; LFA, length-for-age; NW, mothers with normal weight; OW/OB, mothers with
overweight or obesity; WFA, weight-for-age; WFL, weight-for-length.
aEstimates are adjusted for infant sex.
bEstimates are adjusted for infant sex, anthropometric indicator of interest at birth, and feeding preference at the time of anthropometric assessment.
cAll estimates are multiplied by 1-standard deviation of pre-pregnancy BMI (6.4 kg/m2) for population-level relevance.
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behenic acid. The top lipid factor 5 metabolites include N6 LC-
PUFAs, eicosadienoic acid, linoleic acid, adrenic acid, and AA. Lipid
factor 2 score was higher in OW/OB as shown in Table 4.
Milk macronutrient analysis revealed no significant difference
between maternal groups as shown in Table 4. Milk from mothers
with OW/OB had higher insulin levels.
TABLE 3 Human milk long-chain fatty acid profiles
Fatty Acid Component NW (n = 16) OW/OB (n = 16) p
N6:N3 LC-PUFA ratio 12.82 (3.04) 12.98 (3.08) .78
%nmol of total LCFA
Saturated LCFA
14:0, myristic acid 3.75 (0.99) 4.63 (1.76) .09
15:0, pentadecylic acid 0.26 (0.09) 0.28 (0.07) .37
16:0, palmitic acid 21.96 (2.96) 24.34 (2.54) .02
18:0, stearic acid 7.44 (1.86) 7.82 (1.27) .50
19:0, nonadecylic acid 0.14 (0.11) 0.16 (0.09) .29
20:0, arachidic acid 0.22 (0.05) 0.22 (0.03) .95
21:0, heneicosylic acid 0.08 (0.03) 0.10 (0.03) .09
22:0, behenic acid 0.09 (0.04) 0.08 (0.03) .93
24:0, lignoceric acid 0.08 (0.02) 0.09 (0.04) .62
Mono-unsaturated LCFA
14:1 (n-5), myristoleic acid 0.18 (0.08) 0.22 (0.08) .19
16:1 (n-7)c, palmitoleic acid (cis) 2.03 (0.78) 2.40 (0.59) .14
16:1 (n-7)t, palmitoleic acid (trans) 0.24 (0.05) 0.24 (0.05) .87
18:1 (n-7), vaccenic acid 2.83 (0.62) 3.04 (0.63) .34
18:1 (n-9), oleic acid 40.81 (5.16) 36.37 (3.37) .01
20:1, gadoleic acid 0.10 (0.12) 0.2 (0.23) .60
22:1, brassidic acid 0.09 (0.02) 0.10 (0.03) .44
24:1, nervonic acid 0.09 (0.04) 0.10 (0.03) .72
Poly-unsaturated LCFA
18:2 (n-6)cc, linoleic acid (cis) 16.08 (2.93) 15.82 (4.06) .83
18:2 (n-6)tt, linoleic acid (trans) 0.07 (0.04) 0.10 (0.04) .06
18:2 (n-7,9) Conjugate, conjugated linoleic acid 0.45 (0.18) 0.34 (0.18) .02
18:3 (n-3), alpha-linolenic acid 1.02 (0.31) 1.06 (0.59) .52
18:3 (n-6), gamma-linolenic 0.08 (0.03) 0.09 (0.03) .41
18:4 (n-3), stearidonic acid 0.05 (0.03) 0.04 (0.04) .78
20:2 (n-6), eicosadienoic acid 0.38 (0.07) 0.42 (0.10) .21
20:3 (n-6), dihomo-gamma-linolenic acid 0.38 (0.09) 0.54 (0.20) .01
20:4 (n-6), arachidonic acid 0.50 (0.14) 0.58 (0.24) .29
20:5 (n-3), eicosapentaenoic acid 0.07 (0.03) 0.09 (0.07) .62
20:5 (n-6), bosseopentaenoic acid 0.06 (0.01) 0.07 (0.04) .17
22:2 (n-6), docosadienoic acid 0.05 (0.07) 0.03 (0.02) .98
22:4 (n-6), adrenic acid 0.10 (0.04) 0.14 (0.06) .02
22:5 (n-3), docosapentaenoic acid 0.14 (0.08) 0.12 (0.04) .35
22:5 (n-6), osbond acid 0.006 (0.004) 0.006 (0.005) .45
22:6 (n-3), docosahexaenoic acid (DHA) 0.19 (0.16) 0.16 (0.09) .66
Note. Data presented as mean (standard deviation). Values for fatty acids are given as percentage nmol of the fatty acid/total long-chain fatty acid. Bolded
font indicates statistical significance at p < .05 based on a t test or Mann-Whitney U test as appropriate based on distribution.
Abbreviations: LCFA, long-chain fatty acid; N6:N3 LC-PUFA, N6:N3 long-chain polyunsaturated fatty acid; NW, mothers with normal weight; OW/OB,
mothers with overweight or obesity.
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3.3 | Human milk composition and infant growth
We then evaluated milk macronutrient, LCFA factors, N6:N3 LC-
PUFA ratio, and insulin associations with infant growth by WHO Z-
score change from 2 weeks to 2 months and 2 weeks to 6 months as
presented in Table 5 for infants receiving any type of nutrition (which
included any degree of human milk feedings at 2 weeks, 2 months, or
6 months) and infants receiving EHM at 2 weeks, 2 months, and
6 months. Milk fat was positively associated with WFA Z-score
change from 2 weeks to 2 months in EHM-fed infants only with no
other associations between milk macronutrients and infant growth.
N6 LC-PUFA-driven lipid factor 1 and 5 were associated with infant
growth. Lipid factor 1 was associated with higher infant WFL, lower
LFA, and lower HCA Z-score change from 2 weeks to 2 months with
lower HCA Z-score also noted from 2 weeks to 6 months. N6 LC-
PUFA-driven factor 5 was also associated with lower LFA Z-score
change from 2 weeks to 2 months in EHM-fed infants. Milk N6:N3
LC-PUFA ratio was positively associated with infant WFA, WFL, and
BMI Z-score change from 2 weeks to 6 months in infants receiving all
types of nutrition; however, this trend persisted but was no longer
significant when evaluating infants receiving EHM feedings. Milk insu-
lin was positively associated with HCA and WFA Z-score changes in
infants receiving any type of nutrition; however, this association was
small and not significant when evaluating EHM-fed infants.
4 | DISCUSSION
The purpose of this study was to evaluate for associations between
maternal weight status and infant growth, the impact of maternal
weight status on the composition of human milk at 2 weeks post-
partum, and the role of specific milk components in early infant
growth. We found that maternal pre-pregnancy weight status was
positively associated with infant birth WFL and BMI Z-scores.
Mothers with OW/OB were found to have higher LCFAs that may be
obesity promoting but no overall difference in the N6:N3 LC-PUFA
ratio. Milk composition of N6 LC-PUFAs were associated with infant
growth changes over the first months of life in exclusively human
milk-fed infants. Because maternal pre-pregnancy weight status was
not associated with infant growth beyond birth, these associations
highlight the contribution of milk composition in the early postnatal
period to infant growth.
Our study supports prior associations between increased fetal
growth based on birth anthropometrics and maternal pre-pregnancy
BMI (Sewell, Huston-Presley, Super, & Catalano, 2006; Starling et al.,
2015). In this cohort, we did not find an association between maternal
weight status and infant growth beyond birth. Our ability to detect
this difference may be limited by a comparatively small amount of
data. With this lack of association, our study identifies the importance
of alterations in milk as a significant factor in programming of infant
growth outcomes. Studies have shown that rapid early infant growth
by increased WFL Z-score over the first 6 months of life, independent
of maternal BMI, predicted obesity of children at 3 years old (Taveras
et al., 2009). Additional evaluation with a larger cohort and longer
follow-up is necessary to broaden conclusions on the role of milk
composition differences in infant programming.
On the basis of animal models of maternal obesity, altered mam-
mary gland lipogenesis and decreased fatty acid synthesis have been
shown (Saben et al., 2014). Limited human studies on the impact of
maternal obesity on milk lipid composition in mature milk have shown
higher total saturated fatty acids with increased N6:N3 LC-PUFA
ratio, although others have shown increased PUFAs. These outcomes
highlight the need for additional research examining specific maternal
populations and periods of lactation (Makela et al., 2013; Marin,
Sanjurjo, Rodrigo, & de Alaniz, 2005). Our study did not find a differ-
ence in the overall milk N6:N3 LC-PUFA ratio. Many human milk LC-
PUFAs have been shown to be influenced by maternal dietary intake;
however, maternal diet was not assessed in this study.
Fatty acid profile analysis in this study was novel for increased
percentages of potentially obesity-promoting and inflammation-
associated LCFAs, particularly palmitic acid, DGLA, and adrenic acid in
mothers with OW/OB when assessed individually. Although the
mechanisms of action of these fatty acids ingested in milk need fur-
ther elucidation, studies on serum fatty acid level and dietary inter-
vention models give insight. Pro-inflammatory palmitic acid, as seen in
lipid factor 2, has been shown to stimulate inflammatory and meta-
bolic responses through the toll-like receptor signalling pathways, and
diets high in palmitic acid have been associated with lowered fatty
acid oxidation, impaired insulin signalling, and increased fat mass
TABLE 4 Associations of maternal pre-pregnancy weight status









Macronutrients n = 15 n = 15
Protein (g/100 ml) 1.2 ± 0.2 1.2 ± 0.4 .89
Carbohydrate
(g/100 ml)
7.0 ± 0.3 6.8 ± 0.5 .24
Fat (g/100 ml) 3.7 ± 1.1 3.5 ± 0.9 .43
Lipids n = 16 n = 16
Factor 1 −0.23 ± 1.00 0.23 ± 0.98 .18
Factor 2 −0.41 ± 0.87 0.41 ± 0.97 .01
Factor 3 −0.22 ± 0.72 0.22 ± 1.20 .19
Factor 4 0.18 ± 1.34 −0.18 ± 0.46 .29
Factor 5 0.14 ± 0.93 −0.14 ± 1.08 .41
N6:N3 LC-PUFA
ratio
12.8 ± 3.0 13.0 ± 3.1 .88
Metabolic components n = 16 n = 13
Insulin (mU/L) 14.5 ± 15.7 29.5 ± 21.3 .02
Note. Data presented as mean ± standard deviation. Bolded font indicates
statistical significance at p < .05 based on linear regression models.
Abbreviations: N6:N3 LC-PUFA, N6:N3 long-chain polyunsaturated fatty
acid; NW, mothers with normal weight; OW/OB, mothers with
overweight or obesity.
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(Kien, Bunn, & Ugrasbul, 2005; Rogero & Calder, 2018). Studies have
shown that increased insulin results in increased conversion of gamma
linolenic acid to DGLA and decreased conversion to AA (metabolites
in lipid factor 1), which may alter metabolic regulation (Vessby,
Gustafsson, Tengblad, Boberg, & Andersson, 2002). This unique asso-
ciation with insulin may contribute to the findings in our cohort.
DGLA has been identified as a biomarker for obesity with maternal
plasma levels during pregnancy associated with increased childhood
BMI at 7 years (de Vries et al., 2014). Elevated adrenic acid, as seen in
lipid factor 5, has been found in the colostrum of mothers with
OW/OB and plays a protective role in infant brain development
(Hadley, Ryan, Forsyth, Gautier, & Salem, 2016; Sinanoglou et al.,
2017). Oleic acid and conjugated linoleic acid were lower in mothers
with OW/OB in our study. Oleic acid has been shown to reduce obe-
sity and improve metabolic and circulating lipid profiles in adults on
high oleic acid diets (Liu et al., 2016). Although conjugated linoleic acid
found in milk in our diet protects against obesity and diabetes in ani-
mal models, adult human studies have not shown consistent benefits
(Fuke & Nornberg, 2017).
Grouped lipid metabolites identified through PCA provides
insight into potential biological processes impacting infant growth
trends. Lipid factors 1 and 5 highlight distinct lipid metabolite pat-
terns of primarily N6 LC-PUFAs, many of which have been linked to
obesity and adiposity in both children and adults. These factor 5 LC-
PUFAs include linoleic acid-derived eicosadienoic acid, DGLA, and
downstream byproduct AA, which has pro-inflammatory properties,
as does gadoleic acid (de Vries et al., 2014; Kaska et al., 2020;
Vidakovic et al., 2016). In our cohort, lipid factors 1 and 5 were nega-
tively associated with early infant LFA Z-score change and factor
1 positively associated with WFL Z-score change, which may be
driven by reduced length growth. These may be related to the bio-
logical impacts of N6 LC-PUFAs on obesity risk. Additional poten-
tially protective LC-PUFAs are highlighted in lipid factor 3 including
the N3 LC-PUFAs docosahexaenoic acid, docosapenataenoic acid,
which have been shown to be associated with lower body fat in chil-
dren when plasma levels are high in their mothers (Vidakovic et al.,
2016). However, our cohort found no significant impact of this factor
on growth in EHM infants and no overall differences in these top
metabolites between NW and OW/OB mothers. Lipid factor 2 was
composed of saturated fatty acids including palmitic acid, which
alone was higher in OW/OB mothers. The higher palmitic acid may
reflect an overall higher concentration of saturated fatty acids related
to dietary intake in mothers with increased weight status and leads
to mixed infant outcomes (Jenkins, West, & Koulman, 2015; Panagos
et al., 2016; Petersen et al., 2019; Pfeuffer & Jaudszus, 2016;
Vidakovic et al., 2015). This is consistent with a lack of relationship
of lipid factor 2 with infant weight and length growth in our cohort.
Very long-chain fatty acids including lignoceric acid and nervonic
acid, identified as top metabolites contributing to factor 4, have also
been linked to adolescent obesity and metabolic syndrome. There
was, however, no significant impact of factor 4 on growth in our
cohort (Gunes et al., 2014; Karlsson et al., 2006). Studies specifically
evaluating the impact of the lactation period and human milk lipid
composition on infant growth are limited and an area of need for
future research.
With the rising levels of N6:N3 LC-PUFA ratio in the western diet
and epidemic levels of childhood obesity, adipogenic promoting
effects of N6 LC-PUFAs have been hypothesized (Ailhaud & Guesnet,
2004). Our study showed a positive association between milk N6:N3
LC-PUFA ratio and infant growth from 2 weeks to 6 months with
higher infant WFA, WFL, and BMI Z-score change in infants receiving
any degree of human milk with continued positive trends in EHM-fed
infants. Panagos et al. (2016) showed that increased N6:N3 LC-PUFA
ratio was associated with increased WFL Z-score at 2 months. On the
other hand, a human supplementation study showed that milk N6 LC-
PUFAs were negatively associated with infant BMI and lean body
mass at 4 months and increased N3 LC-PUFAs in milk stimulated early
fat accumulation (Much et al., 2013). Given these conflicting results,
research is necessary to arrive at a consensus on the impact of milk
fatty acid profiles on infant growth with studies differentiating early
versus late time frames of lactation.
In this cohort, we found no significant differences in milk macro-
nutrient composition based on maternal weight status. This conserva-
tion of macronutrients, particularly in the initial stages of lactation, is
consistent with milk literature (Ballard & Morrow, 2013). Pre-
pregnancy OW/OB may result in whole body insulin resistance, thus
contributing to altered milk insulin (Badillo-Suarez, Rodriguez-Cruz, &
Nieves-Morales, 2017). Our study showed higher milk insulin in
mothers with OW/OB for milk obtained near 2 weeks postpartum.
Published studies on mature milk insulin in relation to maternal BMI
have shown a positive association with maternal pre-pregnancy BMI
at later time points in lactation (Ahuja et al., 2011; Ley et al., 2012;
Young et al., 2017).
We detected higher insulin levels in milk at 2 weeks in mothers
with elevated BMI and found milk insulin to be positively associated
with higher infant WFA from 2 weeks to 6 months and HCA Z-score
change from 2 weeks to 2 months in infants receiving any type of
nutrition. Given the minimal increases in growth and the lack of asso-
ciation when infants were receiving human milk exclusively, the clini-
cal significance is uncertain. Studies examining associations between
milk insulin and infant weight gain are limited with conflicting results.
Fields et al. reported lower infant weight gain with higher milk insulin
at 1 month; however, further studies by Fields et al. did not show sig-
nificant associations at 6 months of age (Fields et al., 2017; Fields &
Demerath, 2012). A Canadian cohort showed infant WFL Z-score with
milk insulin having a U-shaped association with growth at age 4 (Chan
et al., 2018). Whether ingested milk insulin has biological effect in
infants beyond a role in gut maturation remains controversial, with
some evidence to support that ingested insulin in infants is resistant
to degradation in the stomach and may have systemic effects
(Shehadeh, Sukhotnik, & Shamir, 2006). Further research on the role
of insulin in regulation of infant metabolic health is needed.
This study has several strengths including the analysis of milk
from an early time point when milk is transitioning from colostrum to
mature milk, which has not been included in many milk studies. This
time point allows for unique assessment of lactational programming
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influences on growth outcomes at a time when mothers may be using
less formula supplementation and when milk supply has been
achieved. However, this early-stage milk provides a limited period of
nutrition for infants, and it is important to recognize that mature milk
composition will also contribute to the pattern of ongoing organ
development. This study included milk samples stored at −80C with
analysis within 12 months after collection and minimization of repeti-
tive freeze-thaw cycles, as these factors may impact milk composition
to an unknown degree (George, Gay, Trengove, & Geddes, 2018;
Nessel, Khashu, & Dyall, 2019).
Limitations of this study include a smaller sample size from a
middle-class primarily Caucasian midwestern population, thus the
results may not be applicable to a more diverse population. Other
factors influencing milk composition including maternal diet, vitamin
supplementation, and milk volume were not measured in this study.
As the amount of formula supplementation was not quantified, the
impact on infant growth trajectory may vary on the basis of the
degree of supplementation. When comparing infant growth associa-
tions in Table 5, loss of statistical significance between infants
receiving all feeding types and EHM feeds as well as lack of
growth associations beyond 2 months of age may be in part due
to reduced sample size or additional contributing factors to infant
growth including genetics and environmental influences. Infant
growth assessments were performed by nonresearch medical staff
with weight, length, and head circumference documented in the
medical record. The lack of trained research staff obtaining growth
measurements may introduce inconsistency in infant measurements.
Maternal pre-pregnancy weight similarly was obtained through
medical record review. An assessment of infant body composition
would be of great importance for future work and offer additional
insight than WFL or BMI Z-score alone. Finally, although we used
PCA to consolidate milk LCFAs into lipid metabolite patterns that
likely reflect the clustering of lipids in biochemical pathways, we
assessed other components of milk (macronutrients and insulin)
individually given differences in the unit of measurement for each.
This approach may not accurately represent the interactions among
milk components. Future studies with more sophisticated analytical
techniques to model joint effects of multiple milk components with
health outcomes are warranted.
5 | CONCLUSION
Our study has described early alterations in milk composition with
increases in potentially obesity-promoting fatty acids, reduction in
protective fatty acids, and elevated insulin levels in milk from
mothers with OW/OB. We found associations of higher milk N6
LC-PUFAs with altered infant length growth trajectory through
2 months of age. Although we have shown implications of mater-
nal increased BMI on milk composition and milk composition on
infant growth, our study did not show an overall association
between maternal weight status and infant growth after birth. The
importance of human milk as the primary source of nutrition for
infants cannot be understated; however, as we gain more knowl-
edge regarding the multifaceted and complex changes in milk over
the period of lactation, we must appreciate that factors in milk
may impact early developmental programming. Future research to
understand the complex relationships between maternal health,
milk, and early indicators of programmed infant metabolic disease
risk is important to design interventions to optimize beneficial
aspects of maternal milk for at risk infants.
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